These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21620881)

  • 1. Flu-like symptoms following botulinum toxin therapy.
    Baizabal-Carvallo JF; Jankovic J; Pappert E
    Toxicon; 2011 Jul; 58(1):1-7. PubMed ID: 21620881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
    Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure.
    Dressler D; Bigalke H; Benecke R
    J Neurol; 2003 Aug; 250(8):967-9. PubMed ID: 12928917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flu-like symptoms and associated immunological response following therapy with botulinum toxins.
    Baizabal-Carvallo JF; Jankovic J; Feld J
    Neurotox Res; 2013 Aug; 24(2):298-306. PubMed ID: 23677449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer.
    Chen JJ; Dashtipour K
    Pharmacotherapy; 2013 Mar; 33(3):304-18. PubMed ID: 23400888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and administration of treatment with botulinum neurotoxin for sialorrhoea in ALS patients: review of the literature and a proposal for tailored treatment.
    Stokholm MG; Bisgård C; Vilholm OJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Dec; 14(7-8):516-20. PubMed ID: 23984863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of botulinum neurotoxin therapy].
    Mukai Y; Kaji R
    Brain Nerve; 2011 Jul; 63(7):775-84. PubMed ID: 21747148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain sensation during intradermal injections of three different botulinum toxin preparations in different doses and dilutions.
    Kranz G; Sycha T; Voller B; Gleiss A; Schnider P; Auff E
    Dermatol Surg; 2006 Jul; 32(7):886-90. PubMed ID: 16875469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
    Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
    Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging role of intravesical botulinum toxin therapy in idiopathic detrusor overactivity.
    Patel AK; Patterson JM; Chapple CR
    Int J Clin Pract Suppl; 2006 Dec; (151):27-32. PubMed ID: 17169008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and long-term efficacy of botulinum toxin type B in the treatment of cervical dystonia: report of 4 prospective, multicenter trials.
    Chinnapongse RB; Lew MF; Ferreira JJ; Gullo KL; Nemeth PR; Zhang Y
    Clin Neuropharmacol; 2012; 35(5):215-23. PubMed ID: 22932474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine--a global, evidence-based botulinum toxin consensus education initiative: part I: botulinum toxin in clinical and cosmetic practice.
    Carruthers A; Kane MA; Flynn TC; Huang P; Kim SD; Solish N; Kaeuper G
    Dermatol Surg; 2013 Mar; 39(3 Pt 2):493-509. PubMed ID: 23458294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B.
    Oshima M; Deitiker PR; Jankovic J; Duane DD; Aoki KR; Atassi MZ
    J Neuroimmunol; 2011 Dec; 240-241():121-8. PubMed ID: 22079193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxins in the treatment of primary focal dystonias.
    Truong D
    J Neurol Sci; 2012 May; 316(1-2):9-14. PubMed ID: 22336699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
    Shie JH; Liu HT; Wang YS; Kuo HC
    BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events and health status following botulinum toxin type A injections in children with cerebral palsy.
    O'Flaherty SJ; Janakan V; Morrow AM; Scheinberg AM; Waugh MC
    Dev Med Child Neurol; 2011 Feb; 53(2):125-30. PubMed ID: 21244412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of botulinum toxin type A following long-term use.
    Naumann M; Albanese A; Heinen F; Molenaers G; Relja M
    Eur J Neurol; 2006 Dec; 13 Suppl 4():35-40. PubMed ID: 17112348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule.
    Atassi MZ; Jankovic J; Steward LE; Aoki KR; Dolimbek BZ
    Immunobiology; 2012 Jan; 217(1):17-27. PubMed ID: 21962573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.